Table 1.
Cell line characteristics
| Cell line number | Sex | Age (years) | Primary tumor location | TNM | Specimen site | Type of lesion | Grade | Survival |
|---|---|---|---|---|---|---|---|---|
| UT-SCC-6A | F | 51 | Supraglottic larynx | T2N1M0 | Larynx | rec | G1 | DWD 31 months |
| UT-SCC-6B | F | 51 | Supraglottic larynx | T2N1M0 | Neck | met | G1 | DWD 31 months |
| UT-SCC-8 | M | 42 | Supraglottic larynx | T2N0M0 | Larynx | pri | G1 | DWD 35 months |
| UT-SCC-11 | M | 58 | Glottic larynx | T1N0M0 | Larynx | rec | G2 | DNE >5 years |
| UT-SCC-13 | M | 53 | Supraglottic larynx | T3N0M0 | Larynx | rec | G2 | DWD 11 months |
| UT-SCC-19A | M | 44 | Glottic larynx | T4N0M0 | Larynx | pri | G2 | DNE >5 years |
| UT-SCC-19B | M | 44 | Glottic larynx | T4N0M0 | Larynx | pri (per) | G2 | DNE >5 years |
| UT-SCC-22 | M | 79 | Glottic larynx | T1N0M0 | Larynx | rec | G2 | DWD 28 months |
| UT-SCC-23 | M | 66 | SCC transglottic | T3N0M0 | Larynx | pri (per) | G1 | DNE >5 years |
| UT-SCC-29 | M | 82 | Glottic larynx | T2N0M0 | Larynx | pri | G1 | DNE 10 years and 4 months |
| UT-SCC-34 | M | 63 | Supraglottic larynx | T4N0M0 | Supraglottic larynx | pri | G1 | DWD 10 months |
| UT-SCC-35 | M | 50 | Glottic larynx | T2N0M0 | Larynx | resid | G2 | DWD 10 months |
| UT-SCC-38 | M | 66 | Glottic larynx | T2N0M0 | Larynx | pri | G2 | DWD 16 months |
| UT-SCC-42B | M | 43 | Supraglottic larynx | T4N3M0 | Neck | pri | G3 | DWD 2 months |
| UT-SCC-49 | M | 76 | Glottic larynx | T2N0M0 | Larynx | pri | G2 | DWD 2 years and 7 months |
| UT-SCC-50 | M | 70 | Glottic larynx | T2N0;rT2N0 | Larynx | rec | G3 | ANE >5 years |
| UT-SCC-57 | M | 76 | Glottic larynx | T2N0M0 | Larynx | rec | G1-G2 | DWD 4 years |
| UT-SCC-75 | M | 56 | SCC laryngis | T2N2BM0 | Larynx | pri | G2 | D, NED 2 years and 6 months |
| UT-SCC-106A | M | 59 | SCC plicae vocalis | T1AN0M0 | Larynx | pri | G2 | DNE second pri 4 years and 1 month |
| UT-SCC-106B | M | 59 | SCC plicae vocalis | rT3N0M0 | Larynx | rec | G3 | DWD 5 days |
| UT-SCC-107 | M | 46 | SCC laryngis supraglottis | T4N2CM0 | larynx | pri | G2 | DNE 19 months |
| UT-SCC-108 | M | 68 | SCC laryngis supraglottis | T2N0M0 | larynx | pri | G3 | DWD 19 months |
| UT-SCC-113 | M | 50 | SCC laryngis transglottica | T3N0M0 | larynx | pri | G3 | DWD 17 months |
| UT-SCC-116 | M | 60 | SCC laryngis supraglottis | T4N1M0 | larynx | pri | G2 | DWD 9 months |
| UT-SCC-117 | M | 71 | SCC laryngis (resid T2N0M0) | T2N0M0 | Larynx | rec | G2 | DWD 47 months |
All cell lines were obtained in University of Turku (Finland)
M male, F female, TNM TNM classification (T tumor, N lymph node involvement, M distance metastases), pri primary tumor, rec recurrence, met metastasis, per persistent tumor, DWD died with the disease, DNE died with no disease evident, ANE alive with no disease evident